Institutional Ownership Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA). We have compiled data on the 339 institutions that hold shares in the stock, with a total of 247 Million shares, which have been reported (via 13F filing form) to have a value of $1.38 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
27,534,340
shares
|
$153 Million
0.0% of portfolio
|
Q4 2024
Added 0.81%
|
|
Mhr Fund Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
24,417,103
shares
|
$136 Million
24.02% of portfolio
|
Q4 2024
Added 1.75%
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
22,112,266
shares
|
$123 Million
5.46% of portfolio
|
Q4 2024
Reduced 16.93%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,225,119
shares
|
$118 Million
0.0% of portfolio
|
Q2 2024
Added 6.5%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
12,249,282
shares
|
$68.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.22%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
8,991,573
shares
|
$50 Million
1.15% of portfolio
|
Q4 2024
Added 10.4%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
6,560,000
shares
|
$36.5 Million
3.38% of portfolio
|
Q4 2024
Reduced 23.08%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
5,871,420
shares
|
$32.6 Million
0.0% of portfolio
|
Q4 2024
Added 3.94%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
5,834,456
shares
|
$32.4 Million
0.03% of portfolio
|
Q4 2024
Reduced 0.46%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,175,080
shares
|
$28.8 Million
0.04% of portfolio
|
Q2 2023
Added 436.67%
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Feb 14, 2025 Q4 2024 |
5,132,000
shares
|
$28.5 Million
1.29% of portfolio
|
Q4 2024
Added 13.24%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
4,750,934
shares
|
$26.4 Million
0.04% of portfolio
|
Q4 2024
Added 48.93%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
4,542,168
shares
|
$25.3 Million
0.05% of portfolio
|
Q4 2024
Reduced 5.45%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
4,110,056
shares
|
$22.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 6.38%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,959,839
shares
|
$22 Million
0.0% of portfolio
|
Q4 2024
Added 84.3%
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
3,646,787
shares
|
$20.3 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,500,000
shares
|
$19.5 Million
0.38% of portfolio
|
Q4 2024
Reduced 17.45%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
3,041,685
shares
|
$16.9 Million
3.6% of portfolio
|
Q3 2024
Added 43.72%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,819,799
shares
|
$15.7 Million
0.03% of portfolio
|
Q4 2024
Reduced 36.95%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
2,704,469
shares
|
$15 Million
0.0% of portfolio
|
Q4 2024
Added 334.71%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
2,673,905
shares
|
$14.9 Million
2.96% of portfolio
|
Q4 2024
Added 11.1%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
2,662,695
shares
|
$14.8 Million
0.0% of portfolio
|
Q4 2024
Added 88.32%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,628,101
shares
|
$14.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.3%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,430,221
shares
|
$13.5 Million
0.0% of portfolio
|
Q4 2024
Added 17.43%
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,414,996
shares
|
$13.4 Million
0.05% of portfolio
|
Q4 2024
New holding
|